(Q33623763)

English

Immunogenicity and immunologic memory after hepatitis B virus booster vaccination in HIV-infected children receiving highly active antiretroviral therapy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 July 2017

Immunogenicity and immunologic memory after hepatitis B virus booster vaccination in HIV-infected children receiving highly active antiretroviral therapy (English)

1 reference

Europe PubMed Central

28 July 2017

0 references

anti-retroviral agent

0 references

Hepatitis B virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

4

object named as

Myron J Levin

1 reference

Europe PubMed Central

28 July 2017

5

object named as

Sharon A Nachman

1 reference

Europe PubMed Central

28 July 2017

Stephen I Pelton

6

object named as

Stephen I Pelton

1 reference

Europe PubMed Central

28 July 2017

author name string

Mark J Abzug

1

1 reference

Europe PubMed Central

28 July 2017

Meredith Warshaw

2

1 reference

Europe PubMed Central

28 July 2017

Howard M Rosenblatt

3

1 reference

Europe PubMed Central

28 July 2017

William Borkowsky

7

1 reference

Europe PubMed Central

28 July 2017

Terence Fenton

8

1 reference

Europe PubMed Central

28 July 2017

International Maternal Pediatric Adolescent AIDS Clinical Trials Group P1024 and P1061s Protocol Teams

9

1 reference

Europe PubMed Central

28 July 2017

language of work or name

0 references

publication date

1 September 2009

1 reference

Europe PubMed Central

28 July 2017

Journal of Infectious Diseases

1 reference

Europe PubMed Central

28 July 2017

200

1 reference

Europe PubMed Central

28 July 2017

6

1 reference

Europe PubMed Central

28 July 2017

935-946

1 reference

Europe PubMed Central

28 July 2017

Immune responses in patients with HIV infection after vaccination with recombinant Hepatitis B virus vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

21 June 2018

Antibody responses to hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

21 June 2018

Hepatitis A and B immunizations of individuals infected with human immunodeficiency virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

21 June 2018

Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV-HBV International Panel

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

21 June 2018

Effect of highly active antiretroviral therapy on the serological response to additional measles vaccinations in human immunodeficiency virus-infected children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

21 June 2018

Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

21 June 2018

Response of HIV/AIDS Patients to Hepatitis B Recombinant Vaccine.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

21 June 2018

Response to hepatitis B immunization by infants exposed to HIV.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

21 June 2018

Impaired response to hepatitis B vaccine in HIV infected children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

21 June 2018

Pertussis booster vaccination in HIV-infected children receiving highly active antiretroviral therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

30 October 2018

Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

30 October 2018

Loss of discrete memory B cell subsets is associated with impaired immunization responses in HIV-1 infection and may be a risk factor for invasive pneumococcal disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

30 October 2018

HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

30 October 2018

Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

30 October 2018

Humoral response to hepatitis B vaccination and its relationship with T CD45RA+ (naïve) and CD45RO+ (memory) subsets in HIV-1-infected subjects.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

30 October 2018

Prevalence of protective antibody against hepatitis B virus in HIV-infected children with immune recovery after highly active antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

30 October 2018

Comparative long term immunogenicity of two recombinant hepatitis B vaccines and the effect of a booster dose given after five years in a low endemicity country.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

30 October 2018

Long-term persistence of immunity to hepatitis B after vaccination during infancy in a country where endemicity is low.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

30 October 2018

HLA and cytokine gene polymorphisms are independently associated with responses to hepatitis B vaccination

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

30 October 2018

Efficacy of granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant for hepatitis B virus in patients with HIV infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

30 October 2018

Persistence of antibody and immunologic memory in children immunized with hepatitis B vaccine at birth

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

30 October 2018

Antibody response to hepatitis B immunization in infants born to HIV-infected mothers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

30 October 2018

Serologic response to hepatitis B vaccine in HIV infected and high-risk HIV uninfected adolescents in the REACH cohort. Reaching for Excellence in Adolescent Care and Health.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

30 October 2018

Persistence of immunologic memory for 13 years in recipients of a recombinant hepatitis B vaccine.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

30 October 2018

Persistence of antibodies to the surface antigen of the hepatitis B virus (anti-HBs) in children subjected to the Expanded Programme on Immunization (EPI), including hepatitis-B vaccine, in Thailand.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

30 October 2018

Ten-year serological follow up of hepatitis B vaccine recipients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

30 October 2018

Long-term response to hepatitis B vaccination and response to booster in children born to mothers with hepatitis B e antigen.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

30 October 2018

Hepatitis B vaccination in infants of mothers infected with human immunodeficiency virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

30 October 2018

Hepatitis B vaccination in infants of mothers infected with human immunodeficiency virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

30 October 2018

Undetectable plasma HIV RNA load predicts success after hepatitis B vaccination in HIV-infected persons

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibody response to hepatitis B vaccine in infants of HIV positive mothers

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increasing the number of hepatitis B vaccine injections augments anti-HBs response rate in HIV-infected patients. Effects on HIV-1 viral load

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Persistence of hepatitis B surface antibody levels after vaccination with a recombinant hepatitis B vaccine: a 3-year follow-up study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term efficacy of plasma-derived hepatitis B vaccine: a 15-year follow-up study among Chinese children

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis B vaccination in infancy in The Gambia: protection against carriage at 9 years of age

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long term antibody response to hepatitis B vaccination beginning at birth and to subsequent booster vaccination

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anamnestic response to administration of purified non-adsorbed hepatitis B surface antigen in healthy responders to hepatitis B vaccine with long-term non-protective antibody titres

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunization of HIV-infected children with varicella vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Isolated antibody to hepatitis B core antigen in HIV-1 infected patients and a pilot study of vaccination to determine the anamnestic response

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Poor responses to recombinant HBV vaccination in patients with HIV infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

1 reference

Europe PubMed Central

28 July 2017

1 reference

Europe PubMed Central

28 July 2017

1 reference

Europe PubMed Central

28 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33623763&oldid=1970133029"